Description:
Khloris Biosciences, Inc. is a Delaware-incorporated biotechnology company dedicated to revolutionizing medical treatment of cardiovascular and other diseases with high unmet need with their proprietary platform of disease-specific induced pluripotent stem cells (iPSCs) for innovative drug screening and discovery.